DiFusion Technologies Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

DiFusion Technologies General Information

Description

Operator of a biomaterials development platform intended to develop and commercialize new materials for medical applications. The company's metallic ion therapeutic agents technology offers polymeric implants and a device for reducing the incidence of surgical site infections in orthopedic and spine surgery, enabling medical professionals to mitigate multiple types of bacteria, including MRSA, up to a few weeks postoperatively, reducing hospital-acquired infections or SSIs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1624 Headway Circle
  • Suite 200
  • Austin, TX 78754
  • United States
+1 (512)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Surgical Devices
Vertical(s)
Corporate Office
  • 1624 Headway Circle
  • Suite 200
  • Austin, TX 78754
  • United States
+1 (512)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DiFusion Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 31-Mar-2022 Completed Generating Revenue
3. Later Stage VC 17-Oct-2017 Completed Product In Beta Test
2. Angel (individual) 07-May-2015 $3.92M $9.2M Completed Startup
1. Seed Round 12-Jan-2012 $5.28M $5.28M Completed Startup
To view DiFusion Technologies’s complete valuation and funding history, request access »

DiFusion Technologies Patents

DiFusion Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014152649-A1 Enhanced efficacy self-sterilizing orthopedic implants Inactive 15-Mar-2013
WO-2014152653-A1 Self sterilizing orthopedic implants Inactive 14-Mar-2013
CA-2795836-A1 Medical implant comprising a thermoplastic resin having aluminosilicate particles incorporated therein Active 07-May-2010
CA-2795836-C Medical implant comprising a thermoplastic resin having aluminosilicate particles incorporated therein Active 07-May-2010
EP-2571542-A2 Medical implants with increased hydrophilicity Active 07-May-2010 A61L27/446
To view DiFusion Technologies’s complete patent history, request access »

DiFusion Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DiFusion Technologies Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 6 investors. Get the full list »

DiFusion Technologies FAQs

  • When was DiFusion Technologies founded?

    DiFusion Technologies was founded in 2009.

  • Where is DiFusion Technologies headquartered?

    DiFusion Technologies is headquartered in Austin, TX.

  • What is the size of DiFusion Technologies?

    DiFusion Technologies has 21 total employees.

  • What industry is DiFusion Technologies in?

    DiFusion Technologies’s primary industry is Drug Discovery.

  • Is DiFusion Technologies a private or public company?

    DiFusion Technologies is a Private company.

  • What is DiFusion Technologies’s current revenue?

    The current revenue for DiFusion Technologies is .

  • How much funding has DiFusion Technologies raised over time?

    DiFusion Technologies has raised $12.6M.

  • Who are DiFusion Technologies’s investors?

    , , , , and are 5 of 6 investors who have invested in DiFusion Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process